Results of subxiphoid robotic thymectomy for thymic epithelial tumours more than 5cm

Retrospective study of mediastinal diseases following operative treatment

Status

Recruiting

Phases

Early Phase 1

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR2200055855

Enrollment

Unknown

Registered

2022-01-20

Start date

2022-01-26

Completion date

Unknown

Last updated

2023-07-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Thymic epithelial tumours

Interventions

Smaller tumor (Subxiphoid robotic thymectomy) group:None

Larger tumor (Subxiphoid robotic thymectomy) group:None

Eligibility

Sex/Gender

All

Age

17 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. Patients who undergone subxiphoid robotic thymectomy from September 2016 to September 2020 in our center; 2. The final pathology report is thymoma, thymic carcinoma or thymic neuroendocrine carcinoma.

Exclusion criteria

Exclusion criteria: 1. The final pathology report is thymic hyperplasia, cysts, lymphomas and germ cell tumours; 2. Previous operation history in anterior mediastinum; 3. Palliative operation.

Design outcomes

Primary

Measure	Time frame
Recurrence;Death;Tumor size;Pathology;Comorbidity;Surgical time;Estimated blood loss;Conversion to open;Length of ICU stay;Drainage time;Length of hospital stay;Tumor invasion;Postoperative complication;Postoperative chemoradiotherapy;R0 resection;	—

Secondary

Measure	Time frame
Age;Gender;BMI, body mass index;	—

Countries

China

Contacts

Public ContactWang Yun

Department of Thoracic Surgery, West China Hospital, Sichuan University

yunwwang@yeah.net+86 28 85422494

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026